Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018

Int J Cardiol. 2018 Dec 1:272S:4-10. doi: 10.1016/j.ijcard.2018.09.070. Epub 2018 Sep 20.


The European guidelines, which focus on clinical aspects of pulmonary hypertension (PH), provide only minimal information about the pathophysiological concepts of PH. Here, we review this topic in greater detail, focusing on specific aspects in the pathobiology, pathology and genetics, which include mechanisms of vascular inflammation, the role of transcription factors, ion channels/ion channel diseases, hypoxic pulmonary vasoconstriction, genetics/epigenetics, metabolic dysfunction, and the potential future role of histopathology of PH in the modern era of PH therapy. In addition to new insights in the pathobiology of this disease, this working group of the Cologne Consensus Conference also highlights novel concepts and potential new therapeutic targets to further improve the treatment options in PAH.

Keywords: And the potential future role of histopathology; Genetics/epigenetics; Hypoxic pulmonary vasoconstriction; Inflammation; Ion channels/ion channel diseases; Metabolic dysfunction; Pulmonary hypertension; Transcription factors.

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic / methods
  • Consensus Development Conferences as Topic*
  • Germany / epidemiology
  • Humans
  • Hypertension, Pulmonary / epidemiology
  • Hypertension, Pulmonary / genetics*
  • Hypertension, Pulmonary / metabolism
  • Hypertension, Pulmonary / pathology*
  • Inflammation Mediators / metabolism
  • Vasoconstriction / physiology


  • Inflammation Mediators